Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo

Autor: Cyrus Sinai, Anne W. Rimoin, Stephen G. Higgins, Brian Cowell, Guillaume Ngoie Mwamba, Sue Gerber, Jean-Jacques Muyembe-Tamfum, Nicole A. Hoff, Vivian H. Alfonso, Reena H. Doshi, Ado Bwaka, Emile Okitolonda, Patrick Mukadi
Rok vydání: 2018
Předmět:
Male
Herpesvirus 3
Human

Multivariate analysis
viruses
Antibodies
Viral

medicine.disease_cause
Logistic regression
Pediatrics
Serology
varicella
0302 clinical medicine
Risk Factors
Seroepidemiologic Studies
Epidemiology
Viral
030212 general & internal medicine
Child
varicella zoster virus
Pediatric
Chickenpox
integumentary system
virus diseases
Infectious Diseases
Child
Preschool

Democratic Republic of the Congo
Public Health and Health Services
Female
Infection
Human
Shingles
Microbiology (medical)
medicine.medical_specialty
030231 tropical medicine
herpes zoster
immunization
Article
Antibodies
Paediatrics and Reproductive Medicine
03 medical and health sciences
medicine
Humans
Seroprevalence
Preschool
business.industry
Prevention
Herpesvirus 3
Varicella zoster virus
Infant
medicine.disease
Health Surveys
Virology
vaccine-preventable diseases
Varicella Zoster Virus Infection
Pediatrics
Perinatology and Child Health

Dried Blood Spot Testing
business
Demography
Zdroj: The Pediatric infectious disease journal, vol 37, iss 2
ISSN: 0891-3668
DOI: 10.1097/inf.0000000000001750
Popis: Background Varicella zoster virus (VZV) causes both varicella (chickenpox) and herpes zoster (shingles) and is associated with significant global morbidity. Most epidemiological data on VZV come from high-income countries, and to date there are limited data on the burden of VZV in Africa. Methods We assessed the seroprevalence of VZV antibodies among children in the Democratic Republic of Congo in collaboration with the 2013-2014 Demographic and Health Survey. Dried blood spot samples collected from children 6-59 months of age were run on Dynex™ Technologies Multiplier FLEX® chemiluminescent immunoassay platform to assess serologic response. Multivariate logistic regression was then used to determine risk factors for VZV seropositivity. Results Serologic and survey data were matched for 7,195 children 6-59 months of age, among whom 8% were positive and 2% indeterminate for VZV antibodies in weighted analyses. In multivariate analyses, the odds of seropositivity increased with increasing age, increasing socioeconomic status, mother's education level, rural residence, and province (South Kivu, North Kivu, Bandundu, Bas Congo had the highest odds of a positive test result compared with Kinshasa). Conclusion Our data suggest that VZV is circulating in DRC, and seropositivity is low among children 6-59 months. Seropositivity increased with age and varied by other sociodemographic factors, such as geographic location. This study provides the first nationally representative estimates of VZV infection among children in the DRC.
Databáze: OpenAIRE